Andrea Newkirk

Stock Analyst at Goldman Sachs

(2.92)

# 1,668

Out of 5,090 analysts

4

Total ratings

66.67%

Success rate

51.94%

Average return

Main Sectors:

Top Industries:

Health Information Services Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Andrea Newkirk

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SDGR Schrödinger	Initiates: Neutral	$19	$17.64	+7.71%	1	Sep 30, 2025
	RVMD Revolution Medicines	Maintains: Buy	$65 → $73	$79.64	-8.34%	2	Sep 12, 2025
	ALKS Alkermes	Initiates: Buy	$43	$29.52	+45.66%	1	Jul 15, 2025

Schrödinger

Sep 30, 2025

Initiates: Neutral

Price Target: $19

Current: $17.64

Upside: +7.71%

Revolution Medicines

Sep 12, 2025

Maintains: Buy

Price Target: $65 → $73

Current: $79.64

Upside: -8.34%

Alkermes

Jul 15, 2025

Initiates: Buy

Price Target: $43

Current: $29.52

Upside: +45.66%